Topical Bioavailability
Topical Bioavailability is the fraction of a topically applied drug that reaches the systemic circulation or target site in an active form, distinguishing it from other pharmacokinetic measures by specifically accounting for the drug's absorption and local disposition following non-systemic administration in pediatric dermatotherapeutics.
161
Publications
6.6K
Citations
653
Authors
247
Institutions
Publications per year
2017–2026
38
161
Donatella Paolino, Cinzia Anna Ventura, Steven Paul Nisticò et al. · International Journal of Pharmaceutics · 2002 · 199 citations
Rúbia Casagrande, Sandra R. Georgetti, Waldiceu A. Verri et al. · International Journal of Pharmaceutics · 2006 · 149 citations
1–5 of 161
653
10
h-index
7
h-index
6
h-index
5
h-index
5
h-index
1–5 of 653
247
United States Food and Drug Administration
Silver Spring, United States
11 h-index
20 publications
1.1K citations
University of Michigan
Ann Arbor, United States
9 h-index
27 publications
967 citations

University of Bath
Bath, United Kingdom
8 h-index
34 publications
1.7K citations
Center for Drug Evaluation and Research
Silver Spring, United States
6 h-index
11 publications
560 citations
University of California, San Francisco
San Francisco, United States
6 h-index
14 publications
579 citations
North Carolina State University
Raleigh, United States
5 h-index
19 publications
759 citations

Colorado School of Mines
Golden, United States
5 h-index
8 publications
225 citations
University of Geneva
Geneva, Switzerland
4 h-index
15 publications
810 citations
1–8 of 247
15 publications · 955 citations
15
h-index
12 publications · 596 citations
12
h-index
8 publications · 277 citations
8
h-index
8 publications · 377 citations
8
h-index
JID · 7 publications · 490 citations
7
h-index
1–5